724 5. In up to 90% of patients, optimal medical NBSD management can prevent: a. Vesicoureteral reflux surgery b. Surgical augmentation cystoplasty c. Bladder-outlet surgery References 1. Lapides J, Diokno AC, Silber SJ, Lowe BS (1972) Clean intermittent self-catheterization in the treatment of urinary tract disease. J Urol 107:458–461 2. McGuire EJ, Woodside JR, Bordin TA, Weiss RM (1981) Prognostic value of urodynamic testing in myelodysplastic patients. J Urol 136:205–209 3. Bauer SB, Hallet M, Khoshbin S, Lebowitz RL, Winston KR, Gibson S, Colodny AH, Retik AB (1984) Predictive value of urodynamic evaluation in newborns with myelodysplasia. JAMA 252:650–652 4. Sidi AA, Peng W, Gonzalez R (1986) Vesicoureteral reflux in children with myelodysplasia: natural history and results of treatment. J Urol 136:329–331 5. Smith ED (1972) Urinary prognosis in spina bifida. J Urol 108:815–817 6. van Gool JD (1986) Spina bifida and neurogenic bladder dysfunction—a urodynamic study. Utrecht, Impress 7. Stephenson TP, Wein AJ (1986) The interpretation of urodynam- ics. In Mundy AR, Stephenson TP, Wein A (eds) Urodynamics: principles, practice and application. Churchill Livingstone, Edin- burgh 8. Wang SC, McGuire EJ, Bloom DA (1988) A bladder pressure management system for myelodysplasia–clinical outcome. J Urol 140:1499–1502 9. Steinhardt GF, Goodgold HM, Samuels LD (1988) The effect of intravesical pressure on glomerular filtration rate in patients with myelomeningocele. J Urol 140:1293–1295 10. Rickwood AM, Thomas DG, Philp NH, Spicer RD (1982) Assessment of congenital neurovesical dysfunction by combined urodynamic and radiological studies. Br J Urol 54:512–518 11. Bauer SB, Joseph DB (1990) Management of the obstructed urinary tract associated with neurogenic bladder dysfunction. Urol Clin North Am 17:395–406 12. van Gool JD (1982) Detrusor-sphincter dyssynergia in children with myelomeningocele: a prospective study. Z Kinderchir 37:148–152 13. Mundy AR, Borzyskowski M, Saxton HM (1982) Videourody- namic evaluation of neuropathic vesicoureteral dysfunction in children. J Urol 54:645–649 14. Snodgrass WT, Adams R (2004) Initial urologic management of myelomeningocele. Urol Clin North Am 31:427–434 15. Baskin LS, Kogan BA, Benard F (1990) Treatment of infants with neurogenic bladder dysfunction using anticholinergic drugs and intermittent catheterisation. Br J Urol 66:532–534 16. Fernandes E, Reinberg Y, Vernier R, Gonzales R (1994) Neurogenic bladder dysfunction in children: review of patho- physiology and current management. J Pediatr 124:1–7 17. Jeruto A, Poenaru D, Bransford R (2004) Clean intermittent catheterisation: overview of results in 194 patients with spina bifida. Afr J Pediatr Surg 1:20–23 18. Kari JA (2006) Neuropathic bladder as a cause of chronic renal failure in children in developing countries. Pediatr Nephrol 21:517–520 Pediatr Nephrol (2008) 23:717–725 19. Spindel MR, Bauer SB, Dyro FM, Krarup C, Koshbin S, Winston KR, Lebowitz RL, Colodny AH, Retik AB (1987) The changing neurourologic lesion in myelodysplasia. JAMA 258:1630–1633 20. Tarcan T, Bauer S, Olmedo E, Khoshbin S, Kelly M, Darbey M (2001) Long-term followup of newborns with myelodysplasia and normal urodynamic findings: is follow-up necessary? J Urol 165:564–567 21. Kurzrock EA, Polse S (1998) Renal deterioration in myelodys- plastic children: urodynamic evaluation and clinical correlates. J Urol 159:1657–1661 22. Teichman JM, Scherz HC, Kim KD, Cho DH, Packer MG, Kaplan GW (1994) An alternative approach to myelodysplasia manage- ment: aggressive observation and prompt intervention. J Urol 152:807–811 23. Hopps CV, Kropp KA (2003) Preservation of renal function in children with myelomeningocele managed with basic newborn evaluation and close follow-up. J Urol 169:305–308 24. Joseph DB (1992) The effect of medium-fill and slow-fill saline cystometry on detrusor pressure in infants and children with myelodysplasia. J Urol 147:444–446 25. Bauer SB, Reda EF, Colodny AH, Retik AB (1986) Detrusor instability: a delayed complication in association with the artificial sphincter. J Urol 135:1212–1215 26. Blaivas JG, Labib KL, Bauer SB, Retik AB (1977) A new approach to electromyography of the external urethral spincter. J Urol 117:773–777 27. Joseph DB, Bauer SB, Colodny AH, Mandell J, Retik AB (1989) Clean intermittent catheterization of infants with neurogenic bladder. Pediatrics 84:78–82 28. van Gool JD, Dik P, de Jong TP (2001) Bladder sphincter dysfunction in myelomeningocele. Eur J Pediatr 160:414–420 29. Kessler TM, Lackner J, Kiss G, Rehder P, Madersbacher H (2006) Early proactive management improves upper urinary tract function and reduces the need for surgery in patients with myelomeningo- cele. Neurourol Urodyn 25:758–762 30. Schlager TA, Clark M, Anderson S (2001) Effects of single-use sterile catheter for each void on the frequency of bacteriuria in children with neurogenic bladder on intermittent catheterization for bladder emptying. Pediatrics 108:E71 31. Sutherland RS, Kogan BA, Baskin LS, Mevorach RA (1996) Clean intermittent catheterization in boys using the LOFric catheter. J Urol 156:2041–2043 32. De Swert LF, Van Laer KM, Verpoorten CM, Van Hoeyveld EM, Cadot P, Stevens EA (1997) Determination of independent risk factors and comparative analysis of diagnostic methods for immediate type latex allergy in spina bifida patients. Clin Exp Allergy 27:1067–1076 33. Edelstein RA, Bauer SB, Kelly MD, Darbey MM, Peters CA, Atala A, Mandell J, Colodny AH, Retik AB (1995) The long-term urological response of neonates with myelodysplasia treated proactively with intermittent catheterization and anticholinergic therapy. J Urol 154:1500–1504 34. Andersson KE, Chapple CR (2001) Oxybutynin and the overac- tive bladder. World J Urol 19:319–323 35. Kaefer M, Pabby A, Kelly M, Darbey M, Bauer SB (1999) Improved bladder function after prophylactic treatment of the high risk neurogenic bladder in newborns with myelomeningocele. J Urol 162:1068–1071 36. Aslan AR, Kogan BA (2002) Conservative management in neurogenic bladder dysfunction. Curr Opin Urol 12:473–477 37. Dik P, Klijn AJ, van Gool JD, de Jong-de Vos van Steenwijk CC, de Jong TP (2006) Early start to therapy preserves kidney function in spina bifida patients. Eur Urol 49:908–913 38. Brendler CB, Radebaugh LC, Mohler JL (1989) Topical oxy- butynin chloride for relaxation of dysfunctional bladders. J Urol 141:1350–1352